JY
TNYA icon

Jeff Yass’s Tenaya Therapeutics TNYA Stock Holding History

Jeff Yass’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
325,316
+16,544
+5% +$12.6K ﹤0.01% 11559
2026
Q1 		$214K Buy
308,772
+24,185
+8% +$17.8K ﹤0.01% 11556
2025
Q4 		$202K Sell
284,587
-70,152
-20% -$95.4K ﹤0.01% 10850
2025
Q3 		$575K Buy
354,739
+45,833
+15% +$46.2K ﹤0.01% 8657
2025
Q2 		$189K Buy
308,906
+181,946
+143% +$92.6K ﹤0.01% 11270
2025
Q1 		$72.4K Sell
126,960
-19,802
-13% -$19.5K ﹤0.01% 11728
2024
Q4 		$210K Buy
146,762
+136,423
+1,319% +$306K ﹤0.01% 10631
2024
Q3 		$20K Sell
10,339
-32,679
-76% -$92.3K ﹤0.01% 11626
2024
Q2 		$133K Sell
43,018
-11,435
-21% -$47.2K ﹤0.01% 10813
2024
Q1 		$285K Sell
54,453
-29,870
-35% -$143K ﹤0.01% 9812
2023
Q4 		$273K Buy
+84,323
New +$182K ﹤0.01% 10017
2023
Q3 		– Sell
-71,568
Closed -$420K – 12988
2023
Q2 		$420K Buy
71,568
+10,915
+18% +$63.4K ﹤0.01% 8719
2023
Q1 		$173K Buy
60,653
+40,053
+194% +$113K ﹤0.01% 10773
2022
Q4 		$41.4K Buy
+20,600
New +$50.3K ﹤0.01% 11489

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's TNYA Position: Q2 2026 in Review

Jeff Yass increased its Tenaya Therapeutics (TNYA) stake by 5.4% in Q2 2026, buying an estimated $12.6K and bringing the position to 325,316 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #11559.

Jeff Yass first reported a position in TNYA in Q4 2022 and has held it in 14 quarters since. The position peaked at $575K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Jeff Yass held 325,316 shares of Tenaya Therapeutics worth $240K as of Q2 2026.
  • Jeff Yass bought 16,544 Tenaya Therapeutics shares in Q2 2026, an estimated $12.6K.
  • Tenaya Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11559 holding.
  • Jeff Yass first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • Jeff Yass's Tenaya Therapeutics position peaked at $575K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.